Pacer Advisors, Inc. Celldex Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$32.76 - $42.56 $6,879 - $8,937	-210 Reduced 23.6%	680 $25,000
Q1 2024 May 10, 2024	BUY	$35.22 - $51.88 $31,345 - $46,173	890 New	890 $37,000
Q2 2021 Jul 21, 2021	SELL	$20.71 - $35.37 $58,567 - $100,026	-2,828 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$16.19 - $29.91 $13,405 - $24,765	-828 Reduced 22.65%	2,828 $58,000
Q4 2020 Jan 20, 2021	BUY	$14.99 - $22.75 $54,803 - $83,174	3,656 New	3,656 $64,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.23B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.